Perritt Capital Management Inc Pro Phase Labs, Inc. Put Options Transaction History
Perritt Capital Management Inc
- $180 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.68MCall Options Held
12.3KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$225,6780.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$142,8930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$90,6720.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$80,3080.0% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA218KShares$76,3440.01% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $5.61M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...